# Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)

> **NCT02008578** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 31 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Intravenous hyperimmune immunoglobulin (Flu-IVIG)
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT02008578
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2016-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02008578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02008578, "Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02008578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*